16-1220131-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021098.3(CACNA1H):c.6199G>A(p.Val2067Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,495,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2067A) has been classified as Uncertain significance.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.6199G>A | p.Val2067Ile | missense_variant | Exon 35 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.6214G>A | p.Val2072Ile | missense_variant | Exon 34 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.6184G>A | p.Val2062Ile | missense_variant | Exon 34 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.6181G>A | p.Val2061Ile | missense_variant | Exon 34 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.6181G>A | p.Val2061Ile | missense_variant | Exon 35 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.6166G>A | p.Val2056Ile | missense_variant | Exon 35 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.6160G>A | p.Val2054Ile | missense_variant | Exon 35 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.6148G>A | p.Val2050Ile | missense_variant | Exon 34 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.6142G>A | p.Val2048Ile | missense_variant | Exon 34 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000637236.3 | n.*2118G>A | non_coding_transcript_exon_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.*1247G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*4017G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*5643G>A | non_coding_transcript_exon_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.*1140G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.*1058G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.*1778G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.*866G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.*833G>A | non_coding_transcript_exon_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.*113G>A | non_coding_transcript_exon_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.6199G>A | non_coding_transcript_exon_variant | Exon 35 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.6166G>A | non_coding_transcript_exon_variant | Exon 35 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.*1315G>A | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711483.1 | c.*113G>A | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518772.1 | |||||
CACNA1H | ENST00000711456.1 | c.*113G>A | 3_prime_UTR_variant | Exon 34 of 34 | ENSP00000518769.1 | |||||
CACNA1H | ENST00000637236.3 | n.*2118G>A | 3_prime_UTR_variant | Exon 34 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.*1247G>A | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.*4017G>A | 3_prime_UTR_variant | Exon 35 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*5643G>A | 3_prime_UTR_variant | Exon 33 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.*1140G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.*1058G>A | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.*1778G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.*866G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.*833G>A | 3_prime_UTR_variant | Exon 36 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.*113G>A | 3_prime_UTR_variant | Exon 34 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711488.1 | n.*1315G>A | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711482.1 | c.6122-30G>A | intron_variant | Intron 35 of 35 | ENSP00000518771.1 | |||||
CACNA1H | ENST00000711485.1 | c.6071-30G>A | intron_variant | Intron 34 of 34 | ENSP00000518774.1 | |||||
CACNA1H | ENST00000711455.1 | c.6044-30G>A | intron_variant | Intron 35 of 35 | ENSP00000518768.1 | |||||
CACNA1H | ENST00000621827.2 | n.6121+78G>A | intron_variant | Intron 35 of 36 | 6 | ENSP00000518766.1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152184Hom.: 0 Cov.: 35 show subpopulations
GnomAD2 exomes AF: 0.0000680 AC: 10AN: 147110 AF XY: 0.0000618 show subpopulations
GnomAD4 exome AF: 0.000142 AC: 191AN: 1343102Hom.: 0 Cov.: 31 AF XY: 0.000131 AC XY: 86AN XY: 658236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152302Hom.: 0 Cov.: 35 AF XY: 0.0000537 AC XY: 4AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.6199G>A (p.V2067I) alteration is located in exon 35 (coding exon 34) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 6199, causing the valine (V) at amino acid position 2067 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at